Bortezomib-Containing Regimens Are Effective in Multiple Myeloma - Results of a Non-Interventional Phase IV Study
Wolfgang Knauf(Krankenhaus Bethanien), Andreas Schwarzer, Bernd Gaede, Christoph Tapprich(Johnson & Johnson (Germany)), Burkhard Alkemper(Research Center Borstel - Leibniz Lung Center), Rudolf Schmits(Saarland University), Rudolf Schlag(University of Würzburg), Daniel Reschke(Klinikum Oldenburg), Stefan Schütz(Hochschule Bremerhaven)
Cited by 7
Related Papers
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)
|The Lancet Oncology|2008|1.1k
Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper
|Oncology Research and Treatment|2020|88
Cyclosporine A and Mycophenolate Mofetil vs Cyclosporine A and Methotrexate for graft-versus-host disease prophylaxis after stem cell transplantation from HLA-identical siblings
|Bone Marrow Transplantation|2005|81
Analysis of mitochondrial DNA in 104 patients with myelodysplastic syndromes
|Experimental Hematology|2008|58